Lumi Thera Inc.: Two Year Benefits in Clinical and Anatomical Measures in Intermediate Dry AMD Patients Treated With the Valeda Light Delivery System

Location: 111
Date & Time: Saturday, 21 September, 10:15 - 11:15 CEST
Chairperson(s): M. Munk, SWITZERLAND

Speakers:

Presentations:

M. Munk SWITZERLAND

10:15  Welcome & Introduction

M. Munk SWITZERLAND

10:20  The Science Behind Photobiomodulation Treatment in Dry AMD

M. Munk SWITZERLAND

10:25  LIGHTSITE III 24-Month Clinical Trial Outcomes

G. Jaffe USA

10:35  LIGHTSITE III Anatomical Outcomes and LIGHTSITE IIIB Extension Trial Update

Ø. Utheim NORWAY

10:45  EUROLIGHT Study Update and Real World Patient

M. Munk SWITZERLAND

10:55  Q&A Discussion

Back to Main Programme